Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sustained-release morphine for refractory breathlessness
ACTRN12609000806268Phase 3Completed
- Sponsor
- Flinders University
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Chronic breathlessness syndrome comparing Sustained-release morphine with Placebo (2 arms). Primary endpoint: Primary dyspnoea relief. Started Feb 2010; status: completed.
02
Drugs
morphine
03
Conditions
Chronic breathlessness syndrome
Beyond the preview
Go deeper on ACTRN12609000806268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000806268.